Wertpapierdatensatz · archiviertes Quartal
PTGX
Protagonist Therapeutics, Inc. · Healthcare · Biotechnology
17Erfasste Halter
0Δ Inhaber
26.31MGehaltene Aktien
$1.75BGemeldeter Wert
+2Neue Positionen
−2Ausstiege
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +7.0% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +1 | 45.41M | $5.57B | +7 | −6 |
| Q1 2026 | 108 | -1 | 49.99M | $5.27B | +9 | −10 |
| Q4 2025 | 107 | +4 | 45.87M | $4.01B | +4 | — |
| Q3 2025 | 17 | 0 | 26.31M | $1.75B | +2 | −2 |
| Q2 2025 | 14 | -1 | 22.53M | $1.25B | +1 | −2 |
| Q1 2025 | 12 | +1 | 7.51M | $363.26M | +3 | −2 |
| Q4 2024 | 11 | -2 | 7.82M | $302.00M | — | −2 |
| Q3 2024 | 12 | +2 | 4.92M | $221.52M | +3 | −1 |
| Q2 2024 | 10 | — | 7.44M | $257.83M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passiv) | 9.40M | -2.4% | $624.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 4.26M | -2.3% | $282.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passiv) | 4.26M | -2.3% | $282.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passiv) | 4.26M | -2.3% | $282.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passiv) | 4.26M | -2.3% | $282.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passiv) | 4.26M | -2.3% | $282.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (passiv) | 3.17M | -1.3% | $210.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.91M | +83.9% | $126.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Geode Capital Management ✦ (passiv) | 1.42M | -1.9% | $94.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Geode Capital Management ✦ (passiv) | 1.42M | -1.9% | $94.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 1.22M | +30.3% | $81.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 1.22M | +30.3% | $81.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Marshall Wace ✦ | 1.09M | Neu | $72.11M | 0.1% | New | 1 | SEC ↗ |
| 37 | Marshall Wace ✦ | 1.09M | Neu | $72.11M | 0.1% | New | 1 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 781.71K | — | $51.93M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 781.71K | — | $51.93M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 781.71K | — | $51.93M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 768.36K | — | $51.04M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Adage Capital Partners ✦ | 718.20K | -34.2% | $47.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 51 | Fidelity (FMR) ✦ | 520.66K | -3.3% | $34.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 52 | Fidelity (FMR) ✦ | 520.66K | -3.3% | $34.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | JPMorgan Chase ✦ | 504.80K | — | $33.53M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Citadel Advisors ✦ | 237.88K | +774.5% | $15.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 60 | Citadel Advisors ✦ | 237.88K | +774.5% | $15.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 61 | Duquesne Family Office ✦ | 159.70K | Neu | $10.61M | 0.3% | New | 1 | SEC ↗ |
| 62 | Millennium Management ✦ | 127.56K | +739.7% | $8.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 63 | Gotham Asset Management ✦ | 22.20K | -40.5% | $1.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 64 | AQR Capital Management ✦ | 8.57K | -50.8% | $569,305 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 65 | AQR Capital Management ✦ | 8.57K | -50.8% | $569,305 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 66 | AQR Capital Management ✦ | 8.57K | -50.8% | $569,305 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 67 | AQR Capital Management ✦ | 8.57K | -50.8% | $569,305 | 0.0% | ▼ Trim | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $72.11M | 0.1% |
| Marshall Wace | $72.11M | 0.1% |
| Duquesne Family Office | $10.61M | 0.3% |
Ausgestiegen
| Renaissance Technologies | $9.57M | war 0.0% |
| Arrowstreet Capital | $986,901 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 5.04K Anteile, $530,799 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Aug 11
PATEL DINESH V PH D
Officer, Director · 34.24K Ant. · $5.09M
Aug 10
PATEL DINESH V PH D
Officer, Director · 65.76K Ant. · $9.81M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik
Aug 13
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 07
SC 13G — STATE STREET CORP
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen